María Ángeles Belmonte-López

Effectiveness, predictive response factors, and safety of anti-tumor necrosis factor (TNF) therapies in anti-TNF-naive rheumatoid arthritis.

Antonio Fernández‐Nebro, María Victoria Irigoyen, María Ángeles Belmonte-López et al. · PubMed · 2007 · 49 citations

Medicine, Internal Medicine, Pharmacotherapy +15

Cardiovascular mortality and cardiovascular event rates in patients with inflammatory rheumatic diseases in the CARdiovascular in rheuMAtology (CARMA) prospective study—results at 5 years of follow-up

María Auxiliadora Martín Martínez, Santos Castañeda, Fernando Sánchez‐Alonso et al. · Lara D. Veeken · 2020 · 28 citations

Medicine, Clinical Sciences, Internal Medicine +16

Baseline comorbidities in patients with rheumatoid arthritis who have been prescribed biological therapy: A case control study

Pilar Espiño-Lorenzo, Sara Manrique‐Arija, Inmaculada Ureña‐Garnica et al. · Reumatología Clínica · 2013 · 22 citations

Medicine, Clinical Sciences, Internal Medicine +16

Pure Membranous Lupus Nephritis: Description of a Cohort of 150 Patients and Review of the Literature

Lucía Silva-Fernández, Teresa Otón, Anca Askanase et al. · Reumatología Clínica · 2017 · 16 citations · Full text

Medicine, Nephrology, Pathology +10